Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03244384
Brief Title: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer (AMBASSADOR)

First Submitted : August 7, 2017
First Submitted that Met QC Criteria : August 8, 2017
First Posted : August 9, 2017

Last Update Submitted that Met QC Criteria : February 17, 2020
Last Update Posted : February 18, 2020